Yahoo Web Search

Search results

  1. WHO has published the target product profiles for COVID-19 vaccines, which describes the preferred and minimally acceptable profiles for human vaccines for long term protection of persons at high ongoing risk of COVID-19, and for reactive use in outbreak settings with rapid onset of immunity.

  2. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): PfizerBioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK.

  3. Yes, all WHO emergency-use listed or prequalified COVID-19 vaccines provide protection against severe disease and death from circulating COVID-19 variants. Any of the approved COVID-19 vaccines can be used either for the initial series or revaccination. Vaccination should not be delayed in anticipation of newer versions of the COVID-19 vaccine.

  4. Feb 15, 2021 · WHO’s Emergency Use Listing (EUL) assesses the quality, safety and efficacy of COVID-19 vaccines and is a prerequisite for COVAX Facility vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer COVID-19 vaccines.

  5. The latest data for coronavirus (COVID-19) vaccines and vaccination coverage from the WHO COVID-19 dashboard.

  6. Dec 17, 2021 · The World Health Organization (WHO) approved on Friday the Covovax vaccine for emergency use listing (EUL), elevating to nine the number of immunizations approved to fight the COVID-19...

  7. In the Philippines, available COVID-19 vaccines are from Sinovac Biotech, AstraZeneca, Pfizer-BioNTech, Moderna, Johnson & Johnson, and Sputnik V. These vaccines are categorized by the methods they use to get key vaccine ingredients into our bodies.